Fighting Breast Cancer Stem Cells Through the Immune-Targeting of the xCT Cystine–glutamate Antiporter

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-018-2185-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Glutamate/Cystine xCT Antiporter Antagonizes Glutamine Metabolism and Reduces Nutrient Flexibility

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury

Cellular and Molecular Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Extrasynaptic Glutamate Release Through Cystine/Glutamate Antiporter Contributes to Ischemic Damage

Journal of Clinical Investigation
Medicine
2014English

Retraction Note To: Suppression of the xCT–CD44v Antiporter System Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin

Breast Cancer Research and Treatment
Cancer ResearchOncology
2015English

Targeting xCT, a Cystine-Glutamate Transporter Induces Apoptosis and Tumor Regression for KSHV/HIV-associated Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2014English

Increased Expression of Cystine/Glutamate Antiporter in Multiple Sclerosis

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2011English

Change of Cystine/Glutamate Antiporter Expression in Ethanol-Dependent Rats

Frontiers in Neuroscience
Neuroscience
2014English

Nanocarrier Based Approaches for Targeting Breast Cancer Stem Cells

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2017English

Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy